MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression

Triple-negative breast cancer (TNBC) has a faster rate of metastasis compared to other breast cancer subtypes, and no effective targeted therapies are currently FDA-approved. Recent data indicate that the androgen receptor (AR) promotes tumor survival and may serve as a potential therapeutic target...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Horm Cancer
Autors principals: Christenson, Jessica L., Butterfield, Kiel T., Spoelstra, Nicole S., Norris, John D., Josan, Jatinder S., Pollock, Julie A., McDonnell, Donald P., Katzenellenbogen, Benita S., Katzenellenbogen, John A., Richer, Jennifer K.
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5407486/
https://ncbi.nlm.nih.gov/pubmed/28194662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-017-0285-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars